KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Tax Provisions: 2013-2024

Historic Tax Provisions for Neogenomics (NEO) over the last 12 years, with Dec 2024 value amounting to -$1.9 million.

  • Neogenomics' Tax Provisions rose 593.33% to $740,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$522,000, marking a year-over-year increase of 75.20%. This contributed to the annual value of -$1.9 million for FY2024, which is 78.65% up from last year.
  • Latest data reveals that Neogenomics reported Tax Provisions of -$1.9 million as of FY2024, which was up 78.65% from -$9.1 million recorded in FY2023.
  • Over the past 5 years, Neogenomics' Tax Provisions peaked at -$1.9 million during FY2024, and registered a low of -$18.2 million during FY2020.
  • In the last 3 years, Neogenomics' Tax Provisions had a median value of -$9.1 million in 2023 and averaged -$8.7 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first plummeted by 317.98% in 2020, then surged by 78.65% in 2024.
  • Over the past 5 years, Neogenomics' Tax Provisions (Yearly) stood at -$18.2 million in 2020, then surged by 63.09% to -$6.7 million in 2021, then crashed by 124.32% to -$15.1 million in 2022, then surged by 39.51% to -$9.1 million in 2023, then soared by 78.65% to -$1.9 million in 2024.